肺腺癌多组学整合分析数据表（Table_6）

数据集获取（Figshare）

• 源站标题：Table_6_Multi-Omics Integrative Analysis of Lung Adenocarcinoma: An in silico Profiling for Precise Medicine.XLSX
• DOI：10.3389/fmed.2022.894338.s006
• 发布日期：2022-06-03
• 文件数：1 个
• 文件总体积：29.64 KB
• 源站页面：https://frontiersin.figshare.com/articles/dataset/Table_6_Multi-Omics_Integrative_Analysis_of_Lung_Adenocarcinoma_An_in_silico_Profiling_for_Precise_Medicine_XLSX/19974647

命令行下载

curl -L -o "Table_6_Multi-Omics Integrative Analysis of Lung Adenocarcinoma: An in silico Profiling for Precise Medicine.XLSX" "https://ndownloader.figshare.com/files/35570801"

文件清单

• Table_6_Multi-Omics Integrative Analysis of Lung Adenocarcinoma: An in silico Profiling for Precise Medicine.XLSX（29.64 KB）

文件总体积 29.64 KB（源站 API 实测）。

数据说明

Lung adenocarcinoma (LUAD) is one of the most common histological subtypes of lung cancer. The aim of this study was to construct consensus clusters based on multi-omics data and multiple algorithms. In order to identify specific molecular characteristics and facilitate the use of precision medicine on patients we used gene expression, DNA methylation, gene mutations, copy number variation data, and clinical data of LUAD patients for clustering. Consensus clusters were obtained using a consensus ensemble of five multi-omics integrative algorithms. Four molecular subtypes were identified. The CS1 and CS2 subtypes had better prognosis. Based on the immune and drug sensitivity predictions, we inferred that CS1 may be less responsive to immunotherapy and less sensitive to chemotherapeutic drugs. The high immune infiltration of CS2 cells may respond well to immunotherapy. Additionally, the CS2 subtype may also respond to EGFR molecular targeted therapy. The CS3 and CS4 subtypes were associated with poor prognosis. These two subtypes had more mutations, especially TP53 ones, as well as higher sensitivity to chemotherapeutics for lung cancer. However, CS3 was enriched in immune-related pathways and may respond to anti-PD1 immunotherapy. In addition, CS1 and CS4 were less sensitive to ferroptosis inhibitors. We performed a comprehensive analysis of the five types of omics data using five clustering algorithms to reveal the molecular characteristics of LUAD patients. These findings provide new insights into LUAD subtypes and potential clinical treatment strategies to guide personalized management and treatment.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.3389/fmed.2022.894338.s006（source: https://frontiersin.figshare.com/articles/dataset/Table_6_Multi-Omics_Integrative_Analysis_of_Lung_Adenocarcinoma_An_in_silico_Profiling_for_Precise_Medicine_XLSX/19974647）。